ABOUT THIS STUDY
- To be eligible for enrollment in this study, patients must receive the first injection of Macugen intravitreal in at least one eye for treatment of wet age-related macular degeneration (AMD).
- Active or suspected ocular or periocular infection.
- Known hypersensitivity to pegaptanib sodium or any other excipient in this product.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Navrangpura, Ahemdabad, Gujarat
- Gurgaon, Haryana
- Cochin, Kerala
- Mumbai, Maharashtra
- Jaipur, Rajasthan